Drug Shortage Report for TRILEPTAL 600 MG
Report ID | 175429 |
Drug Identification Number | 02242069 |
Brand name | TRILEPTAL 600 MG |
Common or Proper name | TRILEPTAL 600 MG |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | OXCARBAZEPINE |
Strength(s) | 600MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 5X10 |
ATC code | N03AF |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-11-30 |
Actual start date | 2023-01-27 |
Estimated end date | 2023-01-31 |
Actual end date | 2023-02-08 |
Shortage status | Resolved |
Updated date | 2023-04-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-04-13 | French | Compare |
v6 | 2023-04-13 | English | Compare |
v5 | 2022-12-01 | English | Compare |
v4 | 2022-11-22 | French | Compare |
v3 | 2022-11-22 | English | Compare |
v2 | 2022-11-22 | French | Compare |
v1 | 2022-11-22 | English | Compare |
Showing 1 to 7 of 7